We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Injectable Gel Repairs Damage Caused by Heart Attack

By HospiMedica International staff writers
Posted on 09 Jun 2022
Print article
Image: New gel technology could form a new type of treatment to help hearts regenerate after injury (Photo courtesy of BHF)
Image: New gel technology could form a new type of treatment to help hearts regenerate after injury (Photo courtesy of BHF)

For years, scientists have been looking for ways to introduce new cells into damaged hearts as a way to repair it and reduce the risk of progression to heart failure. But historically, when cells have been injected directly into the heart, only 1% have remained in place and survived. Now, researchers have developed a new biodegradable gel that can be safely injected into the beating heart to act as a scaffold for cells to grow new tissue. The researchers hope their gel will become a key part of future regenerative treatments for damaged hearts.

The new biodegradable gel developed by scientists at the University of Manchester (Manchester, UK) in research funded by the British Heart Foundation (BHF, London, UK) can help to improve the delivery of cells directly into the living heart and could form a new generation of treatments to repair damage caused by a heart attack. The gel is made of chains of amino acids called peptides, the building blocks of proteins. The bonds between the peptides mean that the gel can exist in different states. When it’s under stress the peptides disassemble and behave like a liquid, making it ideal for injecting. When the stress is removed the peptides re-assemble almost immediately and behave like a solid, holding the cells in place as they graft onto the heart.

For any successful treatment, a good blood supply will be vital for the injected cells to develop into new tissue. The researchers saw early signs of blood vessel growth into the gel, proving the technology could boost growth of new vessels. They also showed that the gel can support growth of normal heart muscle tissue. When they added human cells that had been reprogrammed to become heart muscle cells into the gel, they were able to grow them in a dish for three weeks and the cells started to spontaneously beat.

In order to prove that this technology could work in a living heart, the team injected the gel with a fluorescent tag into the hearts of healthy mice. The fluorescent tag revealed that the gel remained in the heart for two weeks. Echocardiograms (ultrasounds of the heart) and electrocardiograms (ECGs, which measure the electrical activity of the heart) confirmed that the injection is safe for the heart. The researchers now plan to trial this treatment in mice straight after a heart attack, to see whether the heart cells can develop new muscle tissue and help restore the heart’s ability to pump efficiently.

“While it’s still early days, the potential this new technology has in helping to repair failing hearts after a heart attack is huge,” said Katharine King, a BHF-funded PhD student at the University of Manchester, who led the research. “We’re confident that this gel will be an effective option for future cell-based therapies to help the damaged heart to regenerate.”

“This new injectable technology harnesses the natural properties of peptides to potentially solve one of the problems that has hindered this type of therapy for years,” added Professor James Leiper, Associate Medical Director at the British Heart Foundation. “If the benefits are replicated in further research and then in patients, these gels could become a significant component of future treatments to repair the damage caused by heart attacks.”

Related Links:
University of Manchester 
BHF


Print article

Channels

AI

view channel
Image: ‘Hologram patients’ developed to help train doctors and nurses (Photo courtesy of University of Cambridge)

Life-Like Hologram Patients Train Doctors for Real-Time Decision Making in Emergencies

A medical training project using 'mixed reality' technology aims to make consistent, high-level and relevant clinical training more accessible across the world. University of Cambridge (Cambridge, UK)... Read more

Surgical Techniques

view channel
Image: The Senhance surgical system with digital laparoscopy (Photo courtesy of Asensus Surgical)

Digital Laparoscopic Platform Leverages Augmented Intelligence and Machine Learning

Challenges in laparoscopic surgery can impact cost, utilization, effectiveness, and outcomes of the procedure. For instance, the inability of the surgeon to control vision can create efficiency and safety... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more

Business

view channel
Image: Expanding the role of autonomous robots can mitigate the shortage of physicians (Photo courtesy of Pexels)

Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries

An aging population and accompanying retirements will cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.